Also trades as: BLCO.TO (TSX) · $vol 0M

$17.11

+0.17 (+1.00%)

Weekly Expected Move ±3.1%

$16 $17 $17 $18 $18

NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 39 · $6.1B mcap · 46M float · 0.900% daily turnover · Short 57% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$5.1B +6.5% ▲

5Y CAGR: +8.4%

Gross Profit

$3.0B +2.6% ▲

5Y CAGR: +7.1%

Operating Income

$159M -1.9% ▼

5Y CAGR: -9.4%

Net Income

-$360M -13.6% ▼

EPS (Diluted)

$-1.02 -13.3% ▼

EBITDA

$572M -4.8% ▼

5Y CAGR: -4.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.8B	$3.8B	$4.1B	$4.8B	$5.1B
YoY Growth	+10.3%	+0.1%	+10.0%	+15.6%	+6.5%
Cost of Revenue	$1.5B	$1.5B	$1.6B	$1.9B	$2.1B
Gross Profit	$2.3B	$2.2B	$2.5B	$2.9B	$3.0B
Gross Margin	61.0%	59.7%	60.4%	60.9%	58.7%
R&D Expenses	$271M	$307M	$324M	$343M	$371M
SG&A Expenses	$1.4B	$1.5B	$1.7B	$2.1B	$2.2B
Operating Expenses	$2.0B	$2.0B	$2.4B	$2.8B	$2.8B
Operating Income	$329M	$207M	$130M	$162M	$159M
Operating Margin	8.7%	5.5%	3.1%	3.4%	3.1%
Interest Expense	$0	$146M	$283M	$399M	$431M
Income Before Tax	$318M	$73M	-$166M	-$234M	-$317M
Tax Expense	$125M	$58M	$82M	$71M	$35M
Net Income	$182M	$6M	-$260M	-$317M	-$360M
Net Margin	4.8%	0.2%	-6.3%	-6.6%	-7.1%
EPS (Diluted)	$0.52	$0.04	$-0.74	$-0.90	$-1.02
EBITDA	$733M	$598M	$499M	$601M	$572M
Shares Outstanding	350M	350M	350M	352M	354M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.2B	$1.3B	$1.1B	$1.3B	$1.3B	$1.4B	$1.2B	$1.4B
Cost of Revenue	$464M	$501M	$482M	$525M	$510M	$589M	$540M	$568M
Gross Profit	$732M	$779M	$655M	$753M	$771M	$816M	$704M	$821M
Gross Margin	61.2%	60.9%	57.6%	58.9%	60.2%	58.1%	56.6%	59.1%
R&D Expenses	$84M	$93M	$86M	$96M	$95M	$94M	$101M	$114M
SG&A Expenses	$511M	$532M	$563M	$579M	$528M	$564M	$544M	$588M
Operating Expenses	$689M	$692M	$738M	$764M	$676M	$658M	$645M	$738M
Operating Income	$43M	$87M	-$83M	-$11M	$95M	$158M	$59M	$83M
Operating Margin	3.6%	6.8%	-7.3%	-0.9%	7.4%	11.2%	4.7%	6.0%
Interest Expense	$100M	$98M	$94M	$128M	$101M	$100M	$100M	$93M
Income Before Tax	-$58M	-$10M	-$180M	-$147M	-$3M	$13M	-$64M	-$11M
Tax Expense	-$66M	-$8M	$31M	-$89M	$22M	$71M	$6M	-$1M
Net Income	$4M	-$3M	-$212M	-$62M	-$28M	-$58M	-$71M	-$14M
Net Margin	0.3%	-0.2%	-18.6%	-4.9%	-2.2%	-4.1%	-5.7%	-1.0%
EPS (Diluted)	$0.01	$-0.01	$-0.60	$-0.18	$-0.08	$-0.16	$-0.20	$-0.04
EBITDA	$152M	$194M	$20M	$88M	$207M	$212M	$137M	$184M
Shares Outstanding	354M	352M	353M	354M	354M	354M	355M	357M

BLCO NYSE